Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma
- DOI
- 10.1186/s13046-025-03620-3
- Published
- 2025-12-26
- Container
- Journal of Experimental & Clinical Cancer Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-025-03620-3,
title = {Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma},
author = {Stefania Elena Navone and Giovanni Marfia and Laura Guarnaccia and Massimiliano Rizzaro and Giorgio Fiore and Rolando Campanella and Chiara Gaudino and Daniele Santini and Giovanni Andrea Alotta and Monica Rosa Miozzo and Emanuela Barilla and Marco Locatelli and Laura Riboni},
year = {2025},
journal = {Journal of Experimental \& Clinical Cancer Research},
doi = {10.1186/s13046-025-03620-3},
url = {https://doi.org/10.1186/s13046-025-03620-3}
}RIS
TY - JOUR TI - Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma AU - Stefania Elena Navone AU - Giovanni Marfia AU - Laura Guarnaccia AU - Massimiliano Rizzaro AU - Giorgio Fiore AU - Rolando Campanella AU - Chiara Gaudino AU - Daniele Santini AU - Giovanni Andrea Alotta AU - Monica Rosa Miozzo AU - Emanuela Barilla AU - Marco Locatelli AU - Laura Riboni PY - 2025 JO - Journal of Experimental & Clinical Cancer Research DO - 10.1186/s13046-025-03620-3 UR - https://doi.org/10.1186/s13046-025-03620-3 ER -
APA
Navone, S. E., Marfia, G., Guarnaccia, L., Rizzaro, M., Fiore, G., Campanella, R., Gaudino, C., Santini, D., Alotta, G. A., Miozzo, M. R., Barilla, E., Locatelli, M., & Riboni, L. (2025). Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-025-03620-3
Source records
- crossref · retrieved 2026-09-26T15:00:47.659Z